If Donald Trump wins the US presidential election in November this could be rather awkward. The HELP Appeal has granted ...

Donanemab is a targeted antibody drug which slows down the early stages of Alzheimer’s. The drug, and another new drug for Alzheimer’s called lecanemab, have been billed as a huge step forward in ...

The environment secretary has said he did not know the company he received a £1,700 football ticket from was linked to a ...

A retired journalist who took part in the clinical trial for the new Alzheimer’s drug has described how he feels “as normal as a 78-year-old can be”. Peter Almond finished a trial for donanemab in ...

The U.K. watchdog declines to endorse Eli Lilly's Alzheimer's drug donanemab, citing lack of value for the NHS and ...

A new Alzheimer’s drug has been rejected for widespread use in the health service in England after the health spending ...

In a blow to tens of thousands of Brits, draft guidance by the NHS spending watchdog ruled the benefits of the drug are far ...

Eli Lilly & Co’s Alzheimer’s drug won’t be made available for patients using England’s National Health Service, after the ...

A new drug that slows the pace of Alzheimer's disease is too expensive for too little benefit to be used on the NHS, the ...

— The Telegraph (@Telegraph) October 22, 2024 The Daily Express lends its front page to a released prisoner who has thanked ...

The most effective drug for Alzheimer’s will be blocked for use on the NHS on Wednesday. Regulators are expected to declare ...

VALPARAISO — A 62-year-old Porter woman faces a felony neglect charge after allegedly leaving a man with advanced Alzhiemer's disease lying unconscious on the floor of his home, records show ...